A study to determine whether introducing a Valsalva assist device into normal ambulance service care can reduce the number of patients with supraventricular tachycardia who need to be taken to hospital.
- Conditions
- Emergency treatment of supraventricular tachycardia (SVT)Circulatory System
- Registration Number
- ISRCTN16145266
- Brief Summary
2023 Protocol article in https://doi.org/10.1136/bmjopen-2023-073315 (added 09/06/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 865
1. Adult patients (above 17 years)
2. Record of a Valsalva manoeuvre for presumed supraventricular tachycardia having been delivered by an ambulance clinician asigned to an ambulance station cluster.
1. Subsequent withdrawal of patient consent to use data
2. Data from participants who are prisoners at the time of treatment
3. Patients with permanent lack of capacity as recorded by the treating clinician
4. Patients solely treated by a SWASFT resource not from one of the included ambulance station clusters e.g. Air Ambulance, Hazardous Area Response Team, Tiverton Minor Injuries Unit, British Association for Immediate Care (BASICS) Doctor
5. Data from patients previously included in the study will be excluded from the primary analysis but will be used in other secondary analyses
6. Patients who have previously registered with the National Data Opt-out service
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Conveyance of patient to hospital as recorded in the Electronic Patient Care Record (ePCR)
- Secondary Outcome Measures
Name Time Method